Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
$35.4m
Enterprise valuation
$26m (Public information from Jun 2023)
Share price
NOK1.156 NANOV.F
Oslo Norway (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | - | <1m | 1.0m | <1m | - | 11.8m |
% growth | (40 %) | - | - | 11 % | (40 %) | - | - |
EBITDA | (20.0m) | (34.7m) | (30.0m) | (40.0m) | (40.0m) | - | (<1m) |
% EBITDA margin | (66667 %) | - | (3333 %) | (4000 %) | (6667 %) | - | (6 %) |
Profit | 20.0m | (32.3m) | 20.0m | 30.0m | 30.0m | (34.2m) | (2.9m) |
% profit margin | 66667 % | - | 2222 % | 3000 % | 5000 % | - | (25 %) |
EV / revenue | - | - | - | - | - | - | 2.4x |
EV / EBITDA | - | - | - | - | - | - | -38.0x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | N/A | IPO | |
N/A | Grant | ||
$1.3m | Grant | ||
N/A | $42.5m | Private Placement VC | |
* | N/A | NOK250m | Private Placement VC |
Total Funding | $74.1m |
Recent News about Nordic Nanovector
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nordic Nanovector
EditACQUISITION by Nordic Nanovector Jun 2023